-+ 0.00%
-+ 0.00%
-+ 0.00%

PROTARA THERAPEUTICS ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 3 REGISTRATIONAL THRIVE-3 TRIAL OF IV CHOLINE CHLORIDE IN PATIENTS ON LONG-TERM PARENTERAL SUPPORT

Reuters·01/07/2026 13:00:03

Please log in to view news